MHRA Safety Roundup: March 2025

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Roundup March 2025 has been published and includes articles on:

  • Prolonged-release opioids: Removal of indication for relief of post-operative pain
  • Suzhou Surgicare disposable Hysteroscopy Sheath – Recall due to withdrawn CE certificate. DSI/2025/001
  • Letters and Recalls in February and March 2025
  • News Roundup – Valproate COVID-19 guidelines, Potency labelling of topical steroids and MHRA Guidance on Safety Communications

To see the latest MHRA Drug Safety Roundup in full, visit the GOV.uk website.

Join us to explore the impact of the CPCF 2025/26 settlement and help set the direction for future negotiating priorities.

Click Here